NCT05518903
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +10 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
Clinical trial condition
Stage I Pancreatic Cancer AJCC v8
Explore clinical trials studying Stage I Pancreatic Cancer AJCC v8. Study availability and eligibility vary by location and protocol.
9 public trials
5 recruiting studies
Stage I Pancreatic Cancer AJCC v8 trial results
NCT07651358
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +8 more
- Locations
-
- OHSU Knight Cancer Institute Portland, Oregon, United States
NCT06423326
- Conditions
- Borderline Resectable Pancreatic Ductal Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, +10 more
- Locations
-
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
NCT07124611
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +9 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
NCT06595160
- Conditions
- Borderline Resectable Pancreatic Ductal Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, +8 more
- Locations
-
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
Active, not recruiting
Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer
NCT04340141
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +10 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Thomas Hospital Fairhope, Alabama, United States
- Mobile Infirmary Medical Center Mobile, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
Active, not recruiting
A Study to Determine if the Drug, Pyrvinium Pamoate, is Safe and Tolerable in Patients With Pancreatic Cancer
NCT05055323
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +13 more
- Locations
-
- Thomas Jefferson University Philadelphia, Pennsylvania, United States
Active, not recruiting
A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma
NCT04111172
- Conditions
- Clinical Stage II Gastric Cancer AJCC v8, Clinical Stage IIA Gastric Cancer AJCC v8, Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8, +50 more
- Locations
-
- Sidney Kimmel Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States
NCT04449679
- Conditions
- Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8, Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8, Clinical Stage 0 Gastric Cancer AJCC v8, +98 more
- Locations
-
- Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States